Skip to content

The effects of Achillea Millefolium on the heavy menstrual bleeding

Investigation the effects of hydro alcoholic extract capsule of Achillea Millefolium on the Menorrhagia of women referred to the health center of Tehran University of medical science in 2015

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041627417N1
Enrollment
126
Registered
2016-05-03
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia. Excessive and frequent menstruation with regular cycle

Interventions

Intervention 1: In intervention group, Mefenamic acid capsules, 500 mg every 8 hours and hydro alcoholic extract of Achillea Millefolium capsules, 150 mg per day, every 8 hours,were prescribed, from t
Treatment - Drugs
Placebo
In intervention group, Mefenamic acid capsules, 500 mg every 8 hours and hydro alcoholic extract of Achillea Millefolium capsules, 150 mg per day, every 8 hours,were prescribed, from the first day to
In control group, Mefenamic acid capsule 500 mg every 8 hours and placebo capsules 150 mg per day, every 8 hours, were prescribed from the first day to the end of bleeding.

Sponsors

Vice chancellor for research Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Body mass index between 18.5-29.9; affected by menorrhagia; age between 18-45 years old; no history of known systemic or pelvic inflammatory diseases; no pregnancy; no consumption of specific medications; no abnormal pap smear or ultrasonography; no history of sensitivity to medicinal plants. Exclusion criteria: sensitivity to the study medications; failure to adhere to prescribed treatment; unwilling to continue participation in the study; tacking any herbal or chemical drug during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount of bleeding. Timepoint: Before treatment, first month during treatment, second month during treatment and one month after the end of treatment. Method of measurement: Higam Chart.

Secondary

MeasureTime frame
Duration of bleeding. Timepoint: Before treatment, first month during treatment, second month during treatment and one month after the end of treatment. Method of measurement: Higam Chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Nahidi

School of Nursing and Midwifery, Shahid Beheshti

nahidi@sbmu.ac.ir; nahidifateme@yahoo.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026